When is tobacco good for you? When it is used to prevent diseases! Biopharmaceutical company Medicago is using wild tobacco plants to make proteins that are part of a new influenza vaccine. These plants serve as natural bioreactors that can make immunogenic nanoparticles, which have been shown to produce a robust immune response in people. Medicago has also developed a method to quickly produce the vaccine in response to a pandemic threat, leading the US government to fund construction of a production center in Research Triangle Park. Come hear more about Medicago’s innovative methods and state-of-the-art facility, which is targeted to produce 10 million doses of pandemic influenza vaccine per month.
About Our Speaker
Dr. Todd Talarico is the Vice President of Process Development and Manufacturing for Medicago. Todd received his Ph.D. in microbiology from NC State and his BS in chemical Engineering from Penn State. Todd has worked in the biotechnology industry developing drugs and vaccines in Research Triangle Park for more than 25 years. He is passionate about his work and making a difference in the health and lives of others.